Full-length LINE-1s with functional ORFs are favoured by host-level selection in human genomes
Heinrich zu DohnaiD, Bo ZhouiD, Xiaowei ZhuiD, Alexander Eckehart UrbaniD
Abstract
The effects of transposable elements, such as LINE-1, on host fitness are still poorly understood. Our analysis of the site frequency spectrum of LINE-1s and SNPs within LINE1s in human genomes shows that selection coefficients are higher for full-length than for fragment LINE-1s and on full-length LINE-1s, SNPs are significantly depleted on ORFs and non-synonymous sites within ORFs. These results suggest that host-level selection maintains transposition competent LINE-1s.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comprehensive scanning mutagenesis of human retrotransposon LINE-1 identifies motifs essential for function
Emily M. Adney, Matthias Thomas Ochmann, … Jef D. Boeke·GeneticsPeer-reviewed·Oct 30, 2019
- Evolutionary insights from profiling LINE-1 activity at allelic resolution in a single human genome
Lei Yang, Genevieve A. Metzger, … Richard N. McLaughlin·The EMBO JournalPeer-reviewed·Dec 18, 2023
- Pangenome reference assemblies reveal the variation and recent activity of human LINE-1 retrotransposons
Lei Yang, Sara Nematbakhsh, … Richard N. McLaughlin·bioRxiv·May 16, 2026
- The MOV10 RNA helicase is a dosage-dependent host restriction factor for LINE1 retrotransposition in mice
Yongjuan Guan, Hongyan Gao, … P. Jeremy Wang·PLoS GeneticsPeer-reviewed·May 1, 2023
- Effect of a LINE1 DNA sequence on expression of long human genes
Jay C. Brown·Genetics & Molecular MedicinePeer-reviewed·Dec 31, 2024
- Characterization of LINE-1 transposons in a human genome at allelic resolution
Lei Yang, Genevieve A. Metzger, Richard N. McLaughlin·bioRxiv·Apr 1, 2019